

Nuwellis shares are surging Thursday afternoon as traders react to new pediatric data tied to the company’s Aquadex ultrafiltration therapy.
You can purchase shares of Nuwellis (NASDAQ:NUWE) through any online brokerage.
Other companies in Nuwellis’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Nuwellis has a consensus price target of $24990.00.
The stock price for Nuwellis (NASDAQ: NUWE) is $0.3316 last updated October 23, 2026 at 7:57 PM EDT.
There are no upcoming dividends for Nuwellis.
Nuwellis does not have any upcoming earnings scheduled.
There is no upcoming split for Nuwellis.
Nuwellis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex...